跳至主要内容
临床试验/NL-OMON40572
NL-OMON40572已完成不适用

Assessment of inflammatory markers in patients with ulcerative colitis treated with tofacitinib - Inflammatory markers in UC

Academisch Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. patients (*18 years) with ulcerative colitis with an indication to start Tofacitinib within the OCTAVE induction study (METC2012_072) and responding to this therapy
  • 2. patients (*18 years) with ulcerative colitis with an indication to start Tofacitinib within the Open Label study (METC_075), after having been defined as a non-responder within the participation in the OCTAVE Induction study (METC2012_072)

排除标准

  • subjects without previous treatment for UC

研究者

相似试验